Sort
11,323 grants matching “glioblastoma”
Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation of Glioblastoma
$1,000,000Evan Charles Unger · Nuvox Pharma, Llc · R44 · FY2022 · CA
TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO
$1,000,000Ajit S Shah · Omniox, Inc. · R44 · FY2014 · CA
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)
$1,000,000Jon O Nagy · Nanovalent Pharmaceuticals, Inc. · R42 · FY2024 · CA
TUMOR RADIOSENSITIZATION USING A NITRIC-OXIDE-NEUTRAL, TUNABLE OXYGEN-BINDING PRO
$1,000,000Ajit S Shah · Omniox, Inc. · R44 · FY2012 · CA
Tumor Antigen Targeted Nanoparticle Therapy for Glioblastoma (GBM)
$1,000,000Jon O Nagy · Nanovalent Pharmaceuticals, Inc. · R42 · FY2025 · CA
Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation of Glioblastoma
$1,000,000Evan Charles Unger · Nuvox Pharma, Llc · R44 · FY2017 · CA
Nanoparticle-based Sensitizer for Radiation Therapy of Glioblastoma
$1,000,000Evan Charles Unger · Nuvox Pharma, Llc · R44 · FY2014 · CA
Expedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients
$999,999Theresa Deisher · Avm Biotechnology, Llc · R44 · FY2022 · CA
Expedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients
$999,999Theresa Deisher · Avm Biotechnology, Llc · R44 · FY2023 · CA
Targeting glioblastoma stem-like cells with custom-designed viral vectors
$999,999Darin J Falk · Lacerta Therapeutics, Inc. · R42 · FY2020 · CA
Targeting glioblastoma stem-like cells with custom-designed viral vectors
$999,999Darin J Falk · Lacerta Therapeutics, Inc. · R42 · FY2019 · CA
TAS::75 0849::TAS
$999,936Paul West · Stemina Biomarker Discovery, Inc. · N44 · FY2010 · CA
Adaptive Clinical Efficacy Evaluation of ONC201 in Recurrent High Grade Glioma
$999,600Wolfgang Oster · Oncoceutics, Inc. · R44 · FY2018 · CA
Adaptive Clinical Efficacy Evaluation of ONC201 in Recurrent High Grade Glioma
$999,600Joshua E. Allen · Oncoceutics, Inc. · R44 · FY2019 · CA
CCR, LGI, Flow Cytometry Core
$999,466Ferenc Livak · Division Of Basic Sciences - Nci · ZIC · FY2018 · CA
Tumor Monorail Device for Serial Glioblastoma Biopsy
$999,360Sean Meehan · Exvade Bioscience, Inc. · R44 · FY2024 · CA
Adaptive Clinical Efficacy Evaluation of ONC201 in Recurrent High Grade Glioma
$999,250Joshua E. Allen · Oncoceutics, Inc. · R44 · FY2020 · CA
NeuroAccess: a Focused Ultrasound System for SonoBiopsy of the Brain
$999,125Bhaskar Ramamurthy · Cordance Medical, Inc. · R44 · FY2025 · CA
Development of Small Molecule Inhibitors and Biologic Agents for Treatment of Glioblastoma Using Intracerebral Microdialysis and Signatures of Vulnerability
$999,063Jana Portnow · Beckman Research Institute/City Of Hope · U19 · FY2021 · CA
Tumor Monorail Device for Serial Glioblastoma Biopsy
$999,038Sean Meehan · Exvade Bioscience, Inc. · R44 · FY2025 · CA
Single-cell Phosphoprotein Assay to Evaluate Brain Tumor Therapeutic Resistance
$999,016Jing Zhou · Isoplexis, Inc. · R44 · FY2019 · CA
SBIR Phase II: Transcranial Dynamic Focused Ultrasound for the Non-Invasive Opening of the Blood-Brain Barrier (BBB)
$998,501Bhaskar S Ramamurthy · Cordance Medical Inc. · · FY2021 · TIP
Spatial genomics analysis of tumor samples
$998,481Kirsten Frieda · Spatial Genomics, Inc. · R44 · FY2024 · CA
Spatial genomics analysis of tumor samples
$998,481Kirsten Frieda · Spatial Genomics, Inc. · R44 · FY2023 · CA
Molecular, Cellular, and Tissue Characterization Unit
$996,148William E Gillanders · Washington University · U2C · FY2018 · CA